We verified higher levels of IL-4 and MMP expression and lower levels of IL-17A and RORC expression using IHC in the pretreatment biopsies of ESCC patients from the Ordos region who achieved CR after CRT compared to those who were non-CR. This evidence concerns the gene IL4 and esophageal squamous cell carcinoma.